REVIVA PHARMACEUTCLS HLDGS I's ticker is RVPHW and the CUSIP is 76152G118. A total of 15 filers reported holding REVIVA PHARMACEUTCLS HLDGS I in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $239,000 | +7.7% | 1,251,250 | +1.3% | 0.01% | -22.2% |
| Q2 2022 | $222,000 | -33.3% | 1,235,000 | +1.2% | 0.01% | -18.2% |
| Q1 2022 | $333,000 | -22.0% | 1,220,600 | 0.0% | 0.01% | -21.4% |
| Q4 2021 | $427,000 | -12.5% | 1,220,600 | 0.0% | 0.01% | +7.7% |
| Q3 2021 | $488,000 | -21.3% | 1,220,600 | 0.0% | 0.01% | +18.2% |
| Q2 2021 | $620,000 | +10.5% | 1,220,600 | 0.0% | 0.01% | +22.2% |
| Q1 2021 | $561,000 | -31.9% | 1,220,600 | 0.0% | 0.01% | -50.0% |
| Q4 2020 | $824,000 | – | 1,220,600 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SABBY MANAGEMENT, LLC | 350,000 | $161,000 | 0.03% |
| BOOTHBAY FUND MANAGEMENT, LLC | 122,160 | $701,000 | 0.03% |
| BlueCrest Capital Management Ltd | 1,220,600 | $561,000 | 0.01% |
| GLAZER CAPITAL, LLC | 690,166 | $317,000 | 0.01% |
| AQR Arbitrage LLC | 250,000 | $115,000 | 0.00% |
| RIVERNORTH CAPITAL MANAGEMENT, LLC | 82,481 | $38,000 | 0.00% |
| Walleye Capital LLC | 64,959 | $30,000 | 0.00% |
| Context Capital Management, LLC | 39,300 | $18,000 | 0.00% |
| HRT FINANCIAL LP | 121,576 | $55,000 | 0.00% |
| UBS Group AG | 12,457 | $6,000 | 0.00% |